Shandong Weigao Blood Purification Products Co., Ltd. (SHA:603014)

China flag China · Delayed Price · Currency is CNY
32.20
+0.02 (0.06%)
At close: Jun 4, 2026
Market Cap13.45B
Revenue (ttm)3.78B +3.2%
Net Income488.24M +6.7%
EPS1.20 -2.5%
Shares Out 417.75M
PE Ratio26.86
Forward PE27.52
Dividend0.52 (1.61%)
Ex-Dividend DateJun 1, 2026
Volume1,179,800
Open32.98
Previous Close32.18
Day's Range32.00 - 32.98
52-Week Range32.10 - 49.01
Betan/a
AnalystsStrong Buy
Price Target49.75 (+54.5%)
Earnings DateAug 28, 2026

About SHA:603014

Shandong Weigao Blood Purification Products Co., Ltd. engages in the research and development, production, and sale of blood purification medical products in China. It offers dialyzers; dialysis machines; hemodialysis tubing, products, and machines; peritoneal dialysis products; dialysis supporting products, such as hemoperfusion devices, dialysis powder and liquid, puncture needles, and iodine caps for peritoneal dialysis. The company was founded in 2004 and is based in Weihai, China. [Read more]

Sector Healthcare
Founded 2004
Employees 3,734
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603014
Full Company Profile

Financial Performance

In 2025, SHA:603014's revenue was 3.77 billion, an increase of 4.57% compared to the previous year's 3.60 billion. Earnings were 482.30 million, an increase of 7.33%.

Financial Statements